SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Lance B's : Its A Beautiful Thing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Allinder who wrote (3594)2/2/2000 1:58:00 PM
From: LANCE B  Read Replies (4) of 4792
 
TNRG- DID YOU KNOW THAT YOU CAN BUY THE FDA APRROVAL DIVISION
FOR .05 CENTS A SHARES....THATS RIGHT THE MEDICAL DIVISON IS DOING THE SPIN OFF FOR A NICKEL A SHARE..

COMTEX) B: TNRG MEDICAL DIVISION RIGHTS OFFERING SHARES TO BE FREELY
B: TNRG MEDICAL DIVISION RIGHTS OFFERING SHARES TO BE FREELY TRADEABLE

NEW YORK, Jan 28, 2000 /PRNewswire via COMTEX/ -- Tianrong Building
Material Holdings, Ltd. (OTC Bulletin Board: TNRG) announced today that
the shares issued in its Medical Division Rights Offering are to be
freely tradeable. The Rights Offering will be pursuant to an exemption
from registration provided by Regulation D, Rule 504 promulgated under
the 1933 Securities Act, as amended.

TNRG intends to register this Rights Offering in a state whose law
requires public filing and delivery of disclosure documents before the
sale of securities in such state. In this manner, the Company will,
after registration in such state, deliver disclosure documents to all
of its shareholders of record (excluding affiliates and controlling
shareholders which includes management) as of March 31, 2000, and
therefore, offer them freely tradeable shares.

All TNRG shareholders as of record date of March 31, 2000 will receive
one (1) right to purchase one (1) share of the common stock of TNRG's
Medical Division for every four (4) shares of TNRG that they own for
$0.05. Affiliates and controlling shareholders, which include
management, shall not be eligible to participate in the Rights
Offering.

James Tilton, President of TNRG, stated, "I am sure that our
shareholders join me in my excitement in the TNRG's Medical Division
Rights Offering."

Tianrong is a business development company that intends to engage in
the acquisition of businesses across several sectors and, through the
application of its management expertise, to enhance shareholder value.

For further information contact investor relations at 800-324-3464 or
visit tnrg.com

This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, which are intended
to be covered by the safe harbors created thereby.

Investors are cautioned that all forward-looking statements involve
risks and uncertainties, including without limitation, the ability of
Tianrong Building Material Holdings to accomplish its stated plan of
business. Tianrong Building Material believes that the assumptions
underlying the forward-looking statements contained herein are
reasonable, any of the assumptions could be inaccurate, and therefore,
there can be no assurance that the forward-looking statements included
in this press release will prove to be accurate. In light of the
significant uncertainties inherent in the forward-looking statements
included herein, the inclusion of such information should not be
regarded as a representation by Tianrong Building Material Holdings or
any other person that the objectives and plans of Tianrong Building
Material Holdings will be achieved.

SOURCE Tianrong Building Material Holdings, Ltd.
(C) 2000 PR Newswire. All rights reserved.
prnewswire.com
-0-
CONTACT: TNRG Investor Relations, 800-324-3464

WEB PAGE: http//www.tnrg.com

GEOGRAPHY: New York

INDUSTRY CODE: FIN
HEA

SUBJECT CODE: OFR
OTC

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext